Ardelyx Inc (ARDX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ardelyx inc   (NASDAQ: ARDX)


Ardelyx Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ardelyx Inc's ROI in the second quarter of 2026?
Ardelyx Inc recorded a cumulative net loss of $-56 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -13.47%.

Within the Healthcare sector 271 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2941 to 3212.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 20.35 % 25.58 % 25.65 % 33.05 % 29.57 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 444 395 413 403 385
Return On Investment (TTM) -13.47 % -14.55 % -16.05 % -15.28 % -16.41 %
ARDX's Overall Ranking # 3212 # 2941 # 2777 # 3028 # 2647
Seq. Investment Change TTM 3.67 % 3.95 % 3.72 % 7.67 % 8.18 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -56 -58 -62 -57 -56

ARDX Company Profile >> Back to ARDX Roi Comparisons >> See Annual ARDX Return On Investment



Return On Investment ARDX's Ranking
Within: No.
Industry # 96
Sector # 272
Overall # 3212

Return On Investment Statistics
High Average Low
1.54 %
-47.98 %
-148.31 %
(Jun 30 2015)   (Jun 30 2022)







Financial Statements
Ardelyx Inc's II. Quarter Investments $ 444 Millions ARDX's Balance sheet
Ardelyx Inc's II. Quarter Income $ -17 Millions Quarterly ARDX's Income Statement
ARDX's Income by Division See ARDX's Income by Division


ARDX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 413 358 247 124 97
Y / Y Investment Growth 15.39 % 44.8 % 98.6 % 28.19 % -43.92 %
Net Income in Millions -62 -39 -66 -67 -158
Y / Y Net Income Growth - - - - -
Annual Return On Investment -14.92 % -10.93 % -26.73 % -54 % -162.9 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ARDX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ARDX's Competitors
Subscribers only: Roi for Ardelyx Inc's Suppliers
Subscribers only: Return On Investment for ARDX's Customers

Other Ratios
ARDX's Roa ARDX's Inventory Turnover Ratio ARDX's Growth Rates ARDX's Dividend Statistics
ARDX's Profitability Ratios ARDX's Asset Turnover Ratio ARDX's Dividend Growth
ARDX's Roe ARDX's Valuation Ratios ARDX's Financial Strength Ratios ARDX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:08:33+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.